In breast cancer nuclear localization of ErbB4 receptor has been demonstrated and nuclear ErbB4 expression has been shown to be associated with unfavorable disease prognosis when compared to membraneous ErbB4 expression [18]. This evidence concerns the gene ERBB4 and breast carcinoma.